NRx Pharmaceuticals, Inc. NRXP
Sector:
HealthcareIndustry:
BiotechnologyDescription:
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics for the treatment of bipolar depression in patients with acute suicidal behavior/ideation and sub-acute suicidal ideation and behavior. The company was founded in 2015 and is based in Wilmington, Delaware.Recent Quarter:
2024-11-14Upcoming Quarter:
2025-03-26Annual Reports
Date2024-04-29
Revenue 0
Net Income -30,150,000
EPS -3.98
Basic Shares 7,576,176
Diluted Shares 7,576,176
Report Link
Date2023-05-01
Revenue 0
Net Income -35,235,000
EPS -0.54
Basic Shares 65,766,785
Diluted Shares 65,766,785
Report Link
Date2022-03-31
Revenue 0
Net Income -71,715,000
EPS -1.53
Basic Shares 46,917,701
Diluted Shares 46,917,701
Report Link
Date2021-04-01
Revenue 0
Net Income -12,347,000
EPS -0.36
Basic Shares 34,270,955
Diluted Shares 34,270,955
Report Link
Date2020-03-30
Revenue 0
Net Income 408,427
EPS 0.8
Basic Shares 508,835
Diluted Shares 508,835
Report Link
Date2019-03-15
Revenue 0
Net Income 66,101
EPS 0.0741
Basic Shares 892,496
Diluted Shares 892,496
Report Link
Date2018-03-23
Revenue 0
Net Income -105,033
EPS -0.12
Basic Shares 903,550
Diluted Shares 903,550
Report Link
Annual Ratios
Date2023-12-31
PE -1.16
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-12-31
PE -20.72
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-12-31
PE -31.27
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-12-31
PE -677.26
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-12-31
PE 132.06
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2018-12-31
PE 1377.20
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2017-12-31
PE -83.27
Dividend Yield 0.00
Payout Ratio: 0.000%
Quarterly Reports
Date2024-11-14
Revenue 0
Net Income -1,623,000
EPS -0.15
Basic Shares 10,973,697
Diluted Shares 10,973,697
Report Link
Date2024-08-14
Revenue 0
Net Income -7,897,000
EPS -0.75
Basic Shares 10,517,460
Diluted Shares 10,517,460
Report Link
Date2024-05-14
Revenue 0
Net Income -6,528,000
EPS -0.74
Basic Shares 8,852,286
Diluted Shares 8,852,286
Report Link
Date2024-04-29
Revenue 8,000
Net Income -4,332,000
EPS -0.0516
Basic Shares 83,919,554
Diluted Shares 83,919,554
Report Link
Date2023-09-30
Revenue 0
Net Income -6,062,000
EPS -0.074
Basic Shares 81,946,957
Diluted Shares 81,946,957
Report Link
Date2023-08-14
Revenue 0
Net Income -8,717,000
EPS -0.12
Basic Shares 73,221,563
Diluted Shares 73,221,563
Report Link
Date2023-05-15
Revenue 0
Net Income -12,643,000
EPS -0.19
Basic Shares 67,453,897
Diluted Shares 67,453,897
Report Link
Date2023-05-01
Revenue 0
Net Income -5,721,000
EPS -0.0861
Basic Shares 66,451,699
Diluted Shares 66,451,699
Report Link
Date2022-11-14
Revenue 0
Net Income -9,025,000
EPS -0.14
Basic Shares 66,449,592
Diluted Shares 66,449,593
Report Link
Date2022-08-15
Revenue 0
Net Income -4,364,000
EPS -0.0664
Basic Shares 65,732,343
Diluted Shares 65,732,343
Report Link
Date2022-05-16
Revenue 0
Net Income -11,191,000
EPS -0.18
Basic Shares 63,667,468
Diluted Shares 63,667,468
Report Link
Date2022-03-31
Revenue 0
Net Income -30,793,054
EPS -0.6
Basic Shares 51,739,452
Diluted Shares 51,739,452
Report Link
Date2021-11-15
Revenue 0
Net Income -20,773,099
EPS -0.38
Basic Shares 54,810,338
Diluted Shares 54,810,338
Report Link
Date2021-08-16
Revenue 0
Net Income -16,007,973
EPS -0.38
Basic Shares 41,727,480
Diluted Shares 42,494,386
Report Link
Date2021-05-21
Revenue 0
Net Income -25,489,000
EPS -0.71
Basic Shares 35,658,216
Diluted Shares 35,658,216
Report Link
Date2021-04-01
Revenue 0
Net Income -45,127,519
EPS -16.73
Basic Shares 2,697,303
Diluted Shares 2,697,303
Report Link
Date2020-11-16
Revenue 0
Net Income -5,161,712
EPS -0.14
Basic Shares 35,658,216
Diluted Shares 35,658,216
Report Link
Date2020-08-14
Revenue 0
Net Income 102,287
EPS 0.0029
Basic Shares 35,658,216
Diluted Shares 35,658,216
Report Link
Date2020-05-15
Revenue 0
Net Income -1,590.0,559,999,999,998
EPS -0.15
Basic Shares 10,689
Diluted Shares 10,689
Report Link
Date2020-03-30
Revenue 0
Net Income -1,664.7,510,000,000,002
EPS -0.16
Basic Shares 10,690
Diluted Shares 10,690
Report Link
Date2019-11-14
Revenue 0
Net Income 59,195
EPS 0.0211
Basic Shares 2,801,350
Diluted Shares 2,801,350
Report Link
Date2019-08-14
Revenue 0
Net Income 176,021
EPS 0.063
Basic Shares 2,794,297
Diluted Shares 2,794,297
Report Link
Date2019-05-15
Revenue 0
Net Income 187,965
EPS 0.069
Basic Shares 2,725,039
Diluted Shares 2,725,039
Report Link
Date2019-03-15
Revenue 0
Net Income 29,139
EPS 0.0107
Basic Shares 2,725,039
Diluted Shares 2,725,039
Report Link
Date2018-11-08
Revenue 0
Net Income 28,084
EPS 0.0107
Basic Shares 2,622,584
Diluted Shares 2,622,584
Report Link
Date2018-08-08
Revenue 0
Net Income -6,602
EPS -0.0025
Basic Shares 2,590,985
Diluted Shares 2,590,985
Report Link
Date2018-05-15
Revenue 0
Net Income 15,481
EPS 0.006
Basic Shares 2,590,985
Diluted Shares 2,590,985
Report Link
Date2018-03-23
Revenue 0
Net Income -105,033
EPS -0.0556
Basic Shares 1,888,881
Diluted Shares 1,888,881
Report Link
Date2017-09-30
Revenue 0
Net Income 0
EPS 0
Basic Shares 1,888,881
Diluted Shares 1,888,881
Report Link
Quarterly Ratios
Date2024-09-30
PE -2.86
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2024-06-30
PE -0.86
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2024-03-31
PE -1.78
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-12-31
PE -22.28
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-09-30
PE -8.79
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-06-30
PE -10.16
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-03-31
PE -8.79
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-12-31
PE -32.23
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-09-30
PE -13.62
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-06-30
PE -22.59
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-03-31
PE -34.85
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-12-31
PE -20.08
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-09-30
PE -61.15
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-06-30
PE -75.72
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-03-31
PE -123.88
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-12-31
PE -3.65
Dividend Yield 4.03
Payout Ratio: -58.783%
Date2020-09-30
PE -18.53
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-06-30
PE 9151.00
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-03-31
PE -181.00
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-12-31
PE -170.17
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-09-30
PE 1251.72
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-06-30
PE 414.73
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-03-31
PE 374.40
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2018-12-31
PE 2384.72
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2018-09-30
PE 233.69
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2018-06-30
PE -9723.06
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2018-03-31
PE 410.88
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2017-12-31
PE -43.52
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2017-09-30
PE 0.00
Dividend Yield 0.00
Payout Ratio: 0.000%
RSI:
41.51Price:
$1.21Market Cap:
14,633,853EPS TTM:
-1.69PE Ratio:
-0.65PEPSG:
NaNFwd PE:
NaNVolume:
122,7802 Year Price Change
0.120Index 2 Year Price Change
1.4975 Year Price Change
0.114Index 5 Year Price Change
1.905PESPG: Growth Rate of EPS projected to next quarter and 6 months trailing. Lower is better to help calculate nexts quarters PE Ratio today. Diluted shares effects the EPS reported and makes calculation show as extremely poor expected growth.
Revenue
Net Income
EPS
Shares
News
Press Releases
Notable Earnings
Please select an option: